IINN Stock Analysis: Buy, Sell, or Hold?
IINN - Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares
$0.73
0.03 (4.92%)
▲
5d:
-8.29%
30d:
-21.23%
90d:
-22.04%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 09, 2026
Get Alerted When IINN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called IINN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IINN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: IINN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: IINN is currently trading at $0.72, which is considered oversold relative to its 30-day fair value range of $0.78 to $0.95. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.6) compared to its historical average (8.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IINN is in a strong downtrend. Immediate support is located at $0.68, while resistance sits at $0.91. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: IINN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+589.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IINN is in a strong downtrend. Immediate support is located at $0.68, while resistance sits at $0.91. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: IINN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+589.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.78 -
$0.95
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 589.7% below Wall St target ($5.00)
- CAUTION: Recommendation downgraded due to -8.3% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.78 -
$0.95
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$0.91
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
6.59
Wall Street Target
$5.00
(+589.7%)
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
6.6 vs 8.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$0.67
(-8%)
2-Year Target
$0.62
(-15%)
3-Year Target
$0.57
(-21%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$0.73
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.6 to 8.4
Stabilization Target:
$0.92
(+27.4%)
PE Expansion Potential:
+27.4%
Last updated: February 03, 2026 4:56 PM ET
Data refreshes hourly during market hours. Next update: 5:56 PM
Data refreshes hourly during market hours. Next update: 5:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IINN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
